HELP | Helus PharmaNASDAQCommon stock golden cross and death cross projections, cross tests and history

$8.80
-$1.79 (-16.94%)

Helus Pharma (HELP) is a NASDAQ-listed common stock that Cruxta has tracked for 50/200 crosses since 2026.

The 50 SMA sits above the 200 on the daily. The 200-day average is 9 sessions old; Cruxta projects nothing until it has 30. Price sits between the 50 and the 200 on the daily and below both on the 4-hour.

Timeframe summary

Daily as of 2 Nov 16:00 ET

Price
between the two $8.80 vs 50 $11.89 / 200 $7.72
Projection
No cross projected
Test
No active test
Last cross
No cross on record

Weekly

No weekly data

Cross history

No 50/200 cross on record for HELP yet.

About HELP

ExchangeNASDAQ
InstrumentCommon stock
Median $ volume, 60 d$16.7M
4-hour coverageYes, since Jan 2026
History on recordSince 2026
Cap bandsmall

Cruxta · 50/200 moving-average crosses on US equities. Recorded crosses are observations. Projected crosses are projections, not advice.